Drug Discovery Outsourcing Market Estimates & Trend Analysis From 2017 to 2030
| Publisher: | Grand View Research |
| Subject: | E-Reports |
| Binding: | Softcover |
The pharmaceutical & biotechnology companies segment accounted for the largest share of over 79.8% in 2022 and is projected to register the highest CAGR during the forecast period. The high growth of the segment is majorly due to the growing rate of pipeline therapeutics,
high R&D investment to develop innovative therapeutics, and increasing outsourcing to reduce cost & focus on core competencies.
To access this content, please contact Knowledge Centre